Announcement 2021-7: Personal protective equipment deductible as medical care expense (COVID-19)
Personal protective equipment deductible
The IRS today released an advance version of Announcement 2021-7 notifying taxpayers that amounts paid for personal protective equipment (PPE) for the primary purpose of preventing the spread of the coronavirus disease 2019 (COVID-19) are treated as amounts paid for medical care under section 213(d).
Announcement 2021-7 [PDF 50 KB] clarifies that:
- The purchase of personal protective equipment—such as masks, hand sanitizer, and sanitizing wipes—for the primary purpose of preventing the spread of COVID-19 is a deductible medical expenses under section 213(a) if purchased for use by the taxpayer, the taxpayer’s spouse or the taxpayer’s dependent(s) and is not compensated for by insurance or otherwise, provided that the taxpayer’s total medical expenses exceed 7.5% of adjusted gross income.
- Amounts paid for personal protective equipment are also eligible to be paid or reimbursed under health flexible spending arrangements (health FSAs), Archer medical savings accounts (Archer MSAs), health reimbursement arrangements (HRAs) or health savings accounts (HSAs). However, any amounts paid or reimbursed under a health FSA, Archer MSA, HRA, HSA or any other health plan are not deductible under section 213(a).
Read related IRS release—IR-2021-66 (March 26, 2021)
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.